Citigroup
SOPH icon

Citigroup’s SOPHiA GENETICS SOPH Stock Holding History

Citigroup’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,389
Closed -$4.31K – 6307
2025
Q2 		$4.31K Buy
1,389
+1,321
+1,943% +$3.94K ﹤0.01% 5294
2025
Q1 		$226 Buy
68
+53
+353% +$186 ﹤0.01% 5411
2024
Q4 		$47 Hold
15
– – ﹤0.01% 5719
2024
Q3 		$55 Hold
15
– – ﹤0.01% 5559
2024
Q2 		$69 Buy
+15
New +$73 ﹤0.01% 5465
2022
Q1 		– Sell
-98
Closed -$1K – 6577
2021
Q4 		$1K Buy
+98
New +$1.45K ﹤0.01% 5778

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Citigroup's SOPH Position: Q3 2025 in Review

Citigroup sold out of SOPHiA GENETICS (SOPH) in Q3 2025, closing a stake of 1,389 shares — an estimated $4.31K sold.

Citigroup first reported a position in SOPH in Q4 2021 and held it in 6 quarters. The position peaked at $4.31K in Q2 2025. 40 funds tracked by Wall St. Rank hold SOPH as of Q3 2025.

  • Citigroup reported no remaining SOPHiA GENETICS position as of Q3 2025 after selling out during the quarter.
  • Citigroup sold 1,389 SOPHiA GENETICS shares in Q3 2025, an estimated $4.31K.
  • Citigroup first reported a position in SOPHiA GENETICS in Q4 2021 and held it in 6 quarters.
  • Citigroup's SOPHiA GENETICS position peaked at $4.31K in Q2 2025.
  • 40 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.